Basic Research

The effects of ERK1/2 inhibitors on the airway hypersecretion of mucin 5ac(Muc5ac)in COPD mice

Expand
  • Department of Respiratory Medicine,the First Affiliated Hospital of Hainan Medical College,Haikou 570102,China

Online published: 2021-05-10

Abstract

Objective To explore the mechanism of extracellular signal ⁃ regulated protein kinase 1/2 (ERK1/2)inhibitor U0126 on airway hypersecretion of mucin 5ac(muc5ac)protein in chronic obstructive pulmo⁃ nary disease(COPD)mice. Methods The pulmonary function indexes,interleukin 4(IL ⁃4)and interferon γ (IFN⁃γ)levels of each group of mice after 7 days of intervention with different drugs were detected.HE staining to observe the pathological changes of lung tissue. RT⁃qPCR was used to detect the expression levels of muc5ac and ERK1/2 mRNA in lung tissues. Western blotting was used to detect the expression levels of muc5ac,ERK1/2,and p⁃ERK1/2 proteins in lung tissue. Results Compared with the model group,the levels of FEV0.3,FVC,FEV0.3/ FVC and IL⁃4 in the inhibitory drug group and the western drug group were increased,whereas the levelsof IFN⁃γ, muc5acmRNA,and the protein expression levels of muc5ac and p⁃ERK1/2 were decreased(P < 0.05). The patho⁃ logical changes of lung tissue improved. Conclusion ERK1/2 inhibitors can reduce the expression of muc5ac by inhibiting the ERK1/2 signaling pathway and improve the symptoms of COPD.

Cite this article

QIN Yingjiao, ZHOU Xiangdong, ZHONG Youqing, WANG Jie, LIU Feng. .

The effects of ERK1/2 inhibitors on the airway hypersecretion of mucin 5ac(Muc5ac)in COPD mice

[J]. The Journal of Practical Medicine, 2021 , 37(9) : 1122 -1126 . DOI: 10.3969/j.issn.1006⁃5725.2021.09.005

Options
Outlines

/